| BRISTOL-MYERS SQUIBBDL-10 |
| USA |
| Gesundheit |
| US1101221083 / 850501 |
| BRM (Frankfurt) / BMY (NYSE) |
| FRA:BRM, ETR:BRM, BRM:GR, NYSE:BMY |
| S&P500 |
| https://www.bms.com/ |
|
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematolo..
>Volltext.. |
| 107816.04 Mio. EUR |
| 137602.84 Mio. EUR |
| 43919.99 Mio. EUR |
| 17137.68 Mio. EUR |
| 8286.72 Mio. EUR |
| 4.06 EUR |
| 40222.12 Mio. EUR |
| 7786.77 Mio. EUR |
| 11411.43 Mio. EUR |
| 0.59 |
| 6.37% |
| 89.62% |
| 2.19 EUR |
| 4.25% |
| 4.25% |
| 02.10.26 - 0.560133€ 02.07.26 - 0.550557€ >weitere anzeigen... |
| - |
| BRISTOL-MYERS, BRISTOL MYERS |
| 14.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|